Dongxing Medical has completed the asset transfer for its cash acquisition of a 90% equity stake in Wuhan Yijiabao Biomaterials Co., Ltd. The target company completed its industrial and commercial registration changes on July 17, obtaining a new business license issued by the Market Supervision Administration of Hongshan District, Wuhan. The delivery of the target shares has been finalized, and Dongxing Medical now directly holds a 90% stake in Yijiabao. According to the agreement, within 10 working days after the equity delivery, Dongxing Medical will pay the first installment of the equity transfer price totaling approximately 577 million yuan to the counterparty, and the payment is currently in progress.
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. ADongxing Medical completed acquisition of 90% stake in Yijiabao, a strategic investment.
Yijiabao is the target of the acquisition; impact depends on integration and future performance.